188 related articles for article (PubMed ID: 3710068)
1. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
Cohen BI; Hofmann AF; Mosbach EH; Stenger RJ; Rothschild MA; Hagey LR; Yoon YB
Gastroenterology; 1986 Jul; 91(1):189-97. PubMed ID: 3710068
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
Miyai K; Javitt NB; Gochman N; Jones HM; Baker D
Lab Invest; 1982 Apr; 46(4):428-37. PubMed ID: 7200166
[TBL] [Abstract][Full Text] [Related]
3. Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N-methyl amino acids.
Schmassmann A; Hofmann AF; Angellotti MA; Ton-Nu HT; Schteingart CD; Clerici C; Rossi SS; Rothschild MA; Cohen BI; Stenger RJ
Hepatology; 1990 Jun; 11(6):989-96. PubMed ID: 2365296
[TBL] [Abstract][Full Text] [Related]
4. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium ursodeoxycholate, hyodeoxycholate and dehydrocholate on cholesterol and bile acid metabolism in rats.
Uchida K; Nomura Y; Kadowaki M; Arisue K; Takeuchi N; Ishikawa Y
J Pharmacobiodyn; 1983 May; 6(5):346-57. PubMed ID: 6620121
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation.
Lake JR; Renner EL; Scharschmidt BF; Cragoe EJ; Hagey LR; Lambert KJ; Gurantz D; Hofmann AF
Gastroenterology; 1988 Aug; 95(2):454-63. PubMed ID: 2455672
[TBL] [Abstract][Full Text] [Related]
7. The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.
Takikawa H; Sano N; Narita T; Yamanaka M
Hepatology; 1990 May; 11(5):743-9. PubMed ID: 2347548
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
Setchell KD; Rodrigues CM; Podda M; Crosignani A
Gut; 1996 Mar; 38(3):439-46. PubMed ID: 8675100
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
Krähenbühl S; Fischer S; Talos C; Reichen J
Hepatology; 1994 Dec; 20(6):1595-601. PubMed ID: 7982660
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate.
Rodrigues CM; Kren BT; Steer CJ; Setchell KD
Gastroenterology; 1995 Aug; 109(2):564-72. PubMed ID: 7615207
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Nakagawa M; Colombo C; Setchell KD
Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
[TBL] [Abstract][Full Text] [Related]
12. Transport, metabolism, and effect of chronic feeding of lagodeoxycholic acid. A new, natural bile acid.
Schmassmann A; Angellotti MA; Clerici C; Hofmann AF; Ton-Nu HT; Schteingart CD; Marcus SN; Hagey LR; Rossi SS; Aigner A
Gastroenterology; 1990 Oct; 99(4):1092-104. PubMed ID: 2394330
[TBL] [Abstract][Full Text] [Related]
13. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
14. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
Kanai S; Sato Y; Nokubo M; Kitani K
Lipids; 1989 Oct; 24(10):859-65. PubMed ID: 2811609
[TBL] [Abstract][Full Text] [Related]
15. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
Nakashima T; Sano A; Seto Y; Nakajima T; Shima T; Sakamoto Y; Okuno T; Kashima K; Hasegawa T
Hepatology; 1990 Feb; 11(2):255-60. PubMed ID: 2307404
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Hofmann AF
Scand J Gastroenterol Suppl; 1994; 204():1-15. PubMed ID: 7824870
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
Tint GS; Bullock J; Batta AK; Shefer S; Salen G
Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
[TBL] [Abstract][Full Text] [Related]
18. The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.
Rodrigues CM; Kren BT; Steer CJ; Setchell KD
Gastroenterology; 1995 Dec; 109(6):1835-44. PubMed ID: 7498648
[TBL] [Abstract][Full Text] [Related]
19. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone.
Kanazawa Y; Koizumi M; Hirakawa H; Endo K; Yoshida S; Miyakawa T; Konno Y; Goto Y; Goto J; Nambara T
Tohoku J Exp Med; 1982 Mar; 136(3):235-49. PubMed ID: 7071843
[TBL] [Abstract][Full Text] [Related]
20. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat.
Zouboulis-Vafiadis I; Dumont M; Erlinger S
Am J Physiol; 1982 Sep; 243(3):G208-13. PubMed ID: 7114264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
